Mr. Ronnie Lee Swaim Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Winston Rd, Jonesville, NC 28642 Phone: 336-835-6407 Fax: 336-526-8329 |
Mrs. Karen R. Sealey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Winston Rd, Jonesville, NC 28642 Phone: 336-835-6407 Fax: 336-526-8329 |
Dr. Rebekah Ann Garris, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Winston Rd, Jonesville, NC 28642 Phone: 336-835-6407 Fax: 336-526-8329 |
Mrs. Mary Lee Souther, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Winston Rd, Jonesville, NC 28642 Phone: 336-835-6407 Fax: 336-526-8329 |
News Archive
This issue includes a feature on designer DNA-binding proteins to combat viral infections in agriculture and medicine; news items include updates of official opening of the Okayama University Silicon Valley Office at Fremont (CA), and international collaboration work with Xiamen University; research highlights on immunizing plants; identification of gene Vrn-D4 for enabling wheat to adapt to areas with warm winters; importance of introgression on intra-specific genetic differentiation and adaptive divergence; an interesting twist on supercooled liquid water; and manufacturing denim in Okayama.
MedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the protein associated with Alzheimer's disease, amyloid-β, might be transmissible under very unusual circumstances, this does not go along with a transmission of the clinical manifestation of Alzheimer's disease. The affected persons develop no clinical symptoms of the disease.
Segasist Technologies, a Canadian software company developing contouring productivity tools for medical imaging, has today announced the receipt of funding from The Health Technology Exchange (HTX) towards support of clinical validation of its software, to be conducted at the Lawson Health Research Institute and London Health Sciences Centre (London, Ontario). Experts from Sunnybrook Research Institute and Sunnybrook Health Sciences Centre will also participate in the validation process by providing input in the form of gold standard contours.
BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.
The frequency of withholding or withdrawing life-prolonging treatment at the end of a patient's life varied greatly among six European countries, according to an article in the February 28 issue of Archives of Internal Medicine.
› Verified 6 days ago